title: Mesial side ovarian incision for laparoscopic dermoid cystectomy: a safe and ovarian tissue-preserving technique.
abstract: OBJECTIVE
  To evaluate safety and efficacy, in terms of spillage risk and ovarian tissue preservation, of mesial incision for laparoscopic dermoid cystectomy.
  
  
  METHODS
  Randomized controlled trial.
  
  
  METHODS
  University.
  
  
  METHODS
  Sixty-seven women with dermoid cysts.
  
  
  METHODS
  Laparoscopic dermoid cystectomy performed by mesial incision (33 patients, study group) or antimesial incision (34 patients, control group).
  
  
  METHODS
  Spillage of intracystic content rate, operative times, chemical peritonitis rate, and intraoperative blood loss (ΔHb) as primary outcomes. Postoperative ovarian reserve (ΔFSH levels, basal antral follicle number, mean ovarian diameter, and peak systolic velocity at 3 and 12 months after surgery) as secondary outcome.
  
  
  RESULTS
  Spillage of intracystic content rate and operative time were significantly lower in the study than in the control group. None developed chemical peritonitis. ΔHb was higher in the study group but not significantly. During the follow-up, median FSH values were significantly lower in the study group, with no differences in the E(2) levels. Moreover, median basal antral follicle number, median ovarian diameter, and median peak systolic velocity were significantly higher in the study group.
  
  
  CONCLUSIONS
  Ovarian mesial-side incision appears to be a safe as well as tissue-sparing technique.
  
  
  BACKGROUND
  .
authors.affiliation: Department of Obstetrics and Gynecology, University Magna Graecia of Catanzaro, Catanzaro, Italy.
authors.forename: Michele
authors.initials: M
authors.lastname: Morelli
authors.forename: Rita
authors.initials: R
authors.lastname: Mocciaro
authors.forename: Roberta
authors.initials: R
authors.lastname: Venturella
authors.forename: Alberto
authors.initials: A
authors.lastname: Imperatore
authors.forename: Daniela
authors.initials: D
authors.lastname: Lico
authors.forename: Fulvio
authors.initials: F
authors.lastname: Zullo
mesh_terms: D015415:Biomarkers / Q000097:blood; D016063:Blood Loss, Surgical; D016009:Chi-Square Distribution; D005260:Female; D059247:Fertility Preservation / Q000009:adverse effects; D043373:Follicle Stimulating Hormone, Human / Q000097:blood; D013509:Gynecologic Surgical Procedures / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D010535:Laparoscopy / Q000009:adverse effects; D059351:Organ Sparing Treatments / Q000009:adverse effects; D006080:Ovarian Follicle / Q000000981:diagnostic imaging / Q000378:metabolism; D010051:Ovarian Neoplasms / Q000601:surgery*; D010053:Ovary / Q000000981:diagnostic imaging / Q000378:metabolism / Q000503:physiopathology / Q000601:surgery*; D010538:Peritonitis / Q000209:etiology; D018570:Risk Assessment; D012307:Risk Factors; D013724:Teratoma / Q000601:surgery*; D013997:Time Factors; D016896:Treatment Outcome; D014463:Ultrasonography
chemical_list: D015415:Biomarkers; D043373:Follicle Stimulating Hormone, Human